drugset / Trial / NCT02299947

Bloodtranfusions After Aortic Surgery

NCT02299947

Phase 4 Terminated 27 enrolled St. Antonius Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to answer the following question: Leads a primary coagulation corrected with a single dose of fibrinogen concentrate after ascending aorta-arc reconstruction to a decrease in the number of allogenic blood transfusions, compared to placebo?

Timeline

Start
2014-08-01
Primary completion
2018-04-26
Completion
2018-04-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic